Titre : Chimérisme

Chimérisme : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chimérisme : Questions médicales les plus fréquentes", "headline": "Chimérisme : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chimérisme : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-28", "dateModified": "2025-04-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chimérisme" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Aberrations des chromosomes", "url": "https://questionsmedicales.fr/mesh/D002869", "about": { "@type": "MedicalCondition", "name": "Aberrations des chromosomes", "code": { "@type": "MedicalCode", "code": "D002869", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.365.590.175" } } }, "about": { "@type": "MedicalCondition", "name": "Chimérisme", "alternateName": "Chimerism", "code": { "@type": "MedicalCode", "code": "D046528", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hui Li", "url": "https://questionsmedicales.fr/author/Hui%20Li", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, VA, United States; Department of Pathology, School of Medicine, University of Virginia, Charlottesville, VA, United States. Electronic address: hl9r@virginia.edu." } }, { "@type": "Person", "name": "Sandeep Singh", "url": "https://questionsmedicales.fr/author/Sandeep%20Singh", "affiliation": { "@type": "Organization", "name": "Department of Pathology, School of Medicine, University of Virginia, Charlottesville, VA, United States." } }, { "@type": "Person", "name": "Hao Zhang", "url": "https://questionsmedicales.fr/author/Hao%20Zhang", "affiliation": { "@type": "Organization", "name": "Institute of Precision Cancer Medicine and Pathology, Jinan University Medical College, Guangzhou, Guangdong, China. haozhang@jnu.edu.cn." } }, { "@type": "Person", "name": "Xinrui Shi", "url": "https://questionsmedicales.fr/author/Xinrui%20Shi", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, VA, United States." } }, { "@type": "Person", "name": "Yusheng Lin", "url": "https://questionsmedicales.fr/author/Yusheng%20Lin", "affiliation": { "@type": "Organization", "name": "Institute of Precision Cancer Medicine and Pathology, Jinan University Medical College, Guangzhou, Guangdong, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Longer cluster hanging time decreases the impact of grapevine red blotch disease in Vitis vinifera L. Merlot across two seasons.", "datePublished": "2023-09-29", "url": "https://questionsmedicales.fr/article/37708393", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jsfa.12983" } }, { "@type": "ScholarlyArticle", "name": "Prognostic value of European Leukemia Net 2022 criteria and genomic clusters using machine learning in older adults with acute myeloid leukemia.", "datePublished": "2023-09-14", "url": "https://questionsmedicales.fr/article/37706344", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3324/haematol.2023.283606" } }, { "@type": "ScholarlyArticle", "name": "A method of water resources accounting based on deep clustering and attention mechanism under the background of integration of public health data and environmental economy.", "datePublished": "2023-09-13", "url": "https://questionsmedicales.fr/article/37810344", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj-cs.1571" } }, { "@type": "ScholarlyArticle", "name": "Characterization, Structure, and Reactivity of Hydroxyl Groups on Metal-Oxide Cluster Nodes of Metal-Organic Frameworks: Structural Diversity and Keys to Reactivity and Catalysis.", "datePublished": "2023-09-03", "url": "https://questionsmedicales.fr/article/37660323", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/adma.202305611" } }, { "@type": "ScholarlyArticle", "name": "24-month outcomes of an eHealth universal program for students and parents to prevent adolescent alcohol use: A cluster randomized controlled trial in schools.", "datePublished": "2023-07-13", "url": "https://questionsmedicales.fr/article/37533974", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.invent.2023.100648" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Variation génétique", "item": "https://questionsmedicales.fr/mesh/D014644" }, { "@type": "ListItem", "position": 4, "name": "Mutation", "item": "https://questionsmedicales.fr/mesh/D009154" }, { "@type": "ListItem", "position": 5, "name": "Aberrations des chromosomes", "item": "https://questionsmedicales.fr/mesh/D002869" }, { "@type": "ListItem", "position": 6, "name": "Chimérisme", "item": "https://questionsmedicales.fr/mesh/D046528" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chimérisme - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chimérisme", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chimérisme", "description": "Comment diagnostiquer le chimérisme ?\nQuels tests sont utilisés pour le chimérisme ?\nLe chimérisme peut-il être détecté par échographie ?\nQuels signes cliniques peuvent indiquer un chimérisme ?\nLe chimérisme est-il héréditaire ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=998#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chimérisme", "description": "Quels sont les symptômes du chimérisme ?\nLe chimérisme cause-t-il des douleurs ?\nPeut-on avoir des symptômes sans chimérisme ?\nLe chimérisme affecte-t-il la croissance ?\nY a-t-il des symptômes spécifiques au chimérisme ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=998#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chimérisme", "description": "Peut-on prévenir le chimérisme ?\nY a-t-il des facteurs de risque pour le chimérisme ?\nLes tests prénataux peuvent-ils détecter le chimérisme ?\nLe chimérisme est-il lié à des pratiques médicales ?\nLes femmes enceintes doivent-elles se méfier du chimérisme ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=998#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chimérisme", "description": "Comment traiter le chimérisme ?\nLe chimérisme nécessite-t-il une intervention chirurgicale ?\nLes médicaments peuvent-ils aider au chimérisme ?\nY a-t-il des traitements naturels pour le chimérisme ?\nLe suivi médical est-il nécessaire pour le chimérisme ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=998#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chimérisme", "description": "Quelles complications peuvent survenir avec le chimérisme ?\nLe chimérisme peut-il causer des cancers ?\nComment gérer les complications du chimérisme ?\nLe chimérisme affecte-t-il le système immunitaire ?\nY a-t-il des risques de rejet avec le chimérisme ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=998#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chimérisme", "description": "Quels sont les facteurs de risque du chimérisme ?\nLe chimérisme est-il plus fréquent chez certaines populations ?\nLes greffes augmentent-elles le risque de chimérisme ?\nLes antécédents médicaux influencent-ils le chimérisme ?\nLe chimérisme est-il lié à des facteurs environnementaux ?", "url": "https://questionsmedicales.fr/mesh/D046528?mesh_terms=Cluster+Analysis&page=998#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le chimérisme ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par analyse génétique, notamment par PCR ou séquençage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le chimérisme ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'analyse de l'ADN, les tests de compatibilité tissulaire et les marqueurs génétiques." } }, { "@type": "Question", "name": "Le chimérisme peut-il être détecté par échographie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'échographie ne peut pas détecter le chimérisme, seul un test génétique est fiable." } }, { "@type": "Question", "name": "Quels signes cliniques peuvent indiquer un chimérisme ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes cliniques peuvent inclure des anomalies immunitaires ou des différences phénotypiques." } }, { "@type": "Question", "name": "Le chimérisme est-il héréditaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, le chimérisme n'est généralement pas héréditaire, il résulte d'événements embryonnaires." } }, { "@type": "Question", "name": "Quels sont les symptômes du chimérisme ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, mais peuvent inclure des anomalies cutanées ou des troubles immunitaires." } }, { "@type": "Question", "name": "Le chimérisme cause-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le chimérisme en soi ne cause pas de douleurs, mais des complications peuvent en entraîner." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans chimérisme ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux symptômes peuvent être causés par d'autres conditions médicales." } }, { "@type": "Question", "name": "Le chimérisme affecte-t-il la croissance ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut affecter la croissance si des anomalies génétiques ou hormonales sont présentes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques au chimérisme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des différences de pigmentation ou des anomalies immunitaires peuvent être spécifiques." } }, { "@type": "Question", "name": "Peut-on prévenir le chimérisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le chimérisme ne peut pas être prévenu car il résulte d'événements embryonnaires." } }, { "@type": "Question", "name": "Y a-t-il des facteurs de risque pour le chimérisme ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque incluent des grossesses multiples ou des transfusions sanguines." } }, { "@type": "Question", "name": "Les tests prénataux peuvent-ils détecter le chimérisme ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les tests prénataux standard ne détectent pas le chimérisme, des tests génétiques spécifiques sont nécessaires." } }, { "@type": "Question", "name": "Le chimérisme est-il lié à des pratiques médicales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines pratiques comme les greffes peuvent augmenter le risque de chimérisme." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles se méfier du chimérisme ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de mesures préventives spécifiques pour les femmes enceintes concernant le chimérisme." } }, { "@type": "Question", "name": "Comment traiter le chimérisme ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend des symptômes et peut inclure des thérapies immunosuppressives." } }, { "@type": "Question", "name": "Le chimérisme nécessite-t-il une intervention chirurgicale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, sauf si des complications graves nécessitent une intervention spécifique." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider au chimérisme ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments immunosuppresseurs peuvent être prescrits pour gérer les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour le chimérisme ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitements naturels prouvés pour le chimérisme, consultez un médecin." } }, { "@type": "Question", "name": "Le suivi médical est-il nécessaire pour le chimérisme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier est essentiel pour surveiller les complications potentielles." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le chimérisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles immunitaires, des rejets de greffe ou des cancers." } }, { "@type": "Question", "name": "Le chimérisme peut-il causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines formes de chimérisme peuvent augmenter le risque de cancers spécifiques." } }, { "@type": "Question", "name": "Comment gérer les complications du chimérisme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi médical régulier et des traitements adaptés aux symptômes." } }, { "@type": "Question", "name": "Le chimérisme affecte-t-il le système immunitaire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le chimérisme peut entraîner des dysfonctionnements du système immunitaire." } }, { "@type": "Question", "name": "Y a-t-il des risques de rejet avec le chimérisme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le rejet peut survenir si des cellules étrangères sont reconnues par le système immunitaire." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du chimérisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les grossesses multiples et les transfusions sanguines sont des facteurs de risque connus." } }, { "@type": "Question", "name": "Le chimérisme est-il plus fréquent chez certaines populations ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de données précises, mais les grossesses multiples peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les greffes augmentent-elles le risque de chimérisme ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les greffes d'organes peuvent introduire des cellules étrangères, entraînant un chimérisme." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le chimérisme ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de transfusions ou de greffes peuvent augmenter le risque de chimérisme." } }, { "@type": "Question", "name": "Le chimérisme est-il lié à des facteurs environnementaux ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de preuves solides liant le chimérisme à des facteurs environnementaux." } } ] } ] }

Sources (10000 au total)

Longer cluster hanging time decreases the impact of grapevine red blotch disease in Vitis vinifera L. Merlot across two seasons.

Grapevine red blotch virus (GRBV) is a recently discovered virus and a major concern for the wine industry. Prior research indicated that GRBV delays grape ripening by reducing °Brix and anthocyanin c... Chemical parameters including phenolic and volatile profiles of grapes and their subsequent wines were measured. Sensory properties were determined by descriptive analyses. Results demonstrated that G... A longer hang time of GRBV grapes is a potential strategy to mitigate the impacts of GRBV. However, chaptalization of diseased fruit must was inefficient at increasing similarities to wines made from ...

24-month outcomes of an eHealth universal program for students and parents to prevent adolescent alcohol use: A cluster randomized controlled trial in schools.

Parents play a critical role in delaying adolescent initiation of alcohol and other drug use. However, the majority of prevention programs focus on adolescents only. This study tested the acceptabilit... A cluster randomized controlled trial (RCT) was conducted between 2018 and 2020 with students from one grade level (aged 12-14 years) from 12 Australian secondary schools randomly allocated to the int... More students in the control group reported having at least one standard alcoholic drink and engaging in heavy episodic drinking in the previous 12 months at both 12- and 24-month follow up compared t... Small sample size, low prevalence of alcohol use and parental engagement, and relatively short follow-up period may have contributed to lack of observed intervention effect, other than on alcohol-rela...

Community-based lifestyle intervention for diabetes (Co-LID study) management rural Nepal: study protocol for a clustered randomized controlled trial.

Type 2 diabetes mellitus (T2DM) has increased globally; with a disproportionate burden in South and Southeast Asian countries, including Nepal. There is an urgent need for clinically and cost-effectiv... We will conduct a cluster randomized control trial to evaluate the effectiveness of community based culturally appropriate lifestyle intervention in improving T2DM outcomes. The trial will be conducte... This study will provide tested approaches for culturally adapting T2DM interventions in the Nepalese context. The findings will also have practice and policy implications for T2DM prevention and manag... Australia and New Zealand Clinical Trial Registry (ACTRN12621000531819). Registered on May 6, 2021....

Unhealthy lifestyles and clusters status among 3637 adolescents aged 11-23 years: a school-based cross-sectional study in China.

Unhealthy lifestyles are risk factors for non-communicable diseases (NCDs) and tend to be clustered, with a trajectory that extends from adolescence to adulthood. This study investigated the associati... In the aggregate, 3,637 adolescents aged 11-23 years were included in the study. The questionnaire collected data on socio-demographic characteristics and lifestyles. Healthy and unhealthy lifestyles ... Among all participants, the prevalence of unhealthy lifestyles was: 86.4% for diet, 14.5% for alcohol, 6.0% for tobacco, 72.2% for PA, 42.3% for ST and 63.9% for SD. Students who were in university, f... In the future, the establishment of an effective public health policy may improve the lifestyle profile of adolescents. Based on the lifestyle characteristics of different populations reported in our ...

Comparison of prevalence, resistance, biofilm-forming ability and virulence between carbapenem-non-susceptible and carbepenem-susceptible Enterobacter cloacae complex in clusters.

This study aimed to explore differences in prevalence, resistance, biofilm-forming ability and virulence between carbapenem-non-susceptible and carbapenem-susceptible Enterobacter cloacae complex (ECC... Ninety-one carbapenem-non-susceptible isolates and an equal number of carbapenem-susceptible isolates and their clinical information were collected from a university teaching hospital in China. The st... The isolates were divided into 12 clusters based on hsp60 analysis. Cluster VIII accounted for a greater proportion of carbapenem-non-susceptible isolates than the other clusters. The same clusters ex... The study findings indicate the need to identify subgroups of ECC, and provide better advice and guidance for the use of carbapenems....

Effect of Structural Moral Case Deliberation on Burnout Symptoms, Moral Distress, and Team Climate in ICU Professionals: A Parallel Cluster Randomized Trial.

Moral case deliberation (MCD) is a team-based and facilitator-led, structured moral dialogue about ethical difficulties encountered in practice. This study assessed whether offering structural MCD in ... This is a parallel cluster randomized trial.... Six ICUs in two hospitals located in Nijmegen, between January 2020 and September 2021.... Four hundred thirty-five ICU professionals.... Three of the ICUs organized structural MCD. In three other units, there was no structural MCD or other structural discussions of moral problems.... The primary outcomes investigated were the three burnout symptoms-emotional exhaustion, depersonalization, and a low sense of personal accomplishment-among ICU professionals measured using the Maslach... Although structural MCD did not mitigate emotional exhaustion or depersonalization, and reduced personal accomplishment in ICU professionals, it did reduce moral distress. Moreover, it did not improve...

Implementing integrated care clinics for HIV-infection, diabetes and hypertension in Uganda (INTE-AFRICA): process evaluation of a cluster randomised controlled trial.

Sub-Saharan Africa is experiencing a dual burden of chronic human immunodeficiency virus and non-communicable diseases. A pragmatic parallel arm cluster randomised trial (INTE-AFRICA) scaled up 'one-s... The PE was conducted in one integrated care clinic, and consisted of 48 in-depth interviews with stakeholders (patients, healthcare providers, policy-makers, international organisation, and clinical r... Four main themes emerged; Implementing the integrated care model within healthcare facilities enhances detection of NCDs and comprehensive co-morbid care; Challenges of NCD drug supply chains; HIV sti... Implementing integrated care has the potential to sustainably reduce duplication of services, improve retention in care and treatment adherence for co/multi-morbid patients, encourage knowledge-sharin... ISRCTN43896688....